Deep tech sustains healthtech dealmaking momentum in SE Asia

Southeast Asia's healthtech sector has defied the wider dealmaking slowdown to maintain its momentum in the first nine months of 2023.

Related Keywords

China ,Singapore ,Indonesia ,Yinglan ,Heilongjiang ,India ,Canton ,Indonesian ,Glympse Bio ,Veronica Utami ,Ankit Agrawal ,Genome Science Initiative Bgsi ,Northstar Group ,Yinglan Tan ,Southeast Asia ,Sunbird Bio ,Quadria Capital ,Genome Science Initiative ,Southeast Asian ,